LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | HG-5-113-01 | 3.33 | uM | LJP5 | 3 | B08 | 72 | hr | 1657 | 2927 | 5505 | 0.5316 | 0.3299 |
BT-20 | HG-5-88-01 | 3.33 | uM | LJP6 | 1 | A20 | 72 | hr | 1657 | 4343 | 5505 | 0.7888 | 0.6979 |
BT-20 | HG-5-88-01 | 3.33 | uM | LJP6 | 2 | A20 | 72 | hr | 1657 | 4615 | 5505 | 0.8382 | 0.7685 |
BT-20 | HG-5-88-01 | 3.33 | uM | LJP6 | 3 | A20 | 72 | hr | 1657 | 4459 | 5505 | 0.8099 | 0.7280 |
BT-20 | Imatinib | 3.33 | uM | LJP6 | 1 | N14 | 72 | hr | 1657 | 5377 | 5505 | 0.9766 | 0.9666 |
BT-20 | Imatinib | 3.33 | uM | LJP6 | 2 | N14 | 72 | hr | 1657 | 5730 | 5505 | 1.0407 | 1.0583 |
BT-20 | Imatinib | 3.33 | uM | LJP6 | 3 | N14 | 72 | hr | 1657 | 5412 | 5505 | 0.9830 | 0.9757 |
BT-20 | JNK-9L | 3.33 | uM | LJP6 | 1 | K20 | 72 | hr | 1657 | 1470 | 5505 | 0.2670 | -0.0488 |
BT-20 | JNK-9L | 3.33 | uM | LJP6 | 2 | K20 | 72 | hr | 1657 | 1481 | 5505 | 0.2690 | -0.0459 |
BT-20 | JNK-9L | 3.33 | uM | LJP6 | 3 | K20 | 72 | hr | 1657 | 1607 | 5505 | 0.2919 | -0.0132 |
BT-20 | JW-7-24-1 | 3.33 | uM | LJP6 | 1 | B20 | 72 | hr | 1657 | 3931 | 5505 | 0.7140 | 0.5908 |
BT-20 | JW-7-24-1 | 3.33 | uM | LJP6 | 2 | B20 | 72 | hr | 1657 | 4185 | 5505 | 0.7601 | 0.6568 |
BT-20 | JW-7-24-1 | 3.33 | uM | LJP6 | 3 | B20 | 72 | hr | 1657 | 4034 | 5505 | 0.7327 | 0.6175 |
BT-20 | Lapatinib | 3.33 | uM | LJP6 | 1 | M20 | 72 | hr | 1657 | 4492 | 5505 | 0.8159 | 0.7366 |
BT-20 | Lapatinib | 3.33 | uM | LJP6 | 2 | M20 | 72 | hr | 1657 | 5186 | 5505 | 0.9419 | 0.9169 |
BT-20 | Lapatinib | 3.33 | uM | LJP6 | 3 | M20 | 72 | hr | 1657 | 4927 | 5505 | 0.8949 | 0.8496 |
BT-20 | LDN-193189 | 3.33 | uM | LJP5 | 1 | G02 | 72 | hr | 1657 | 1956 | 5505 | 0.3553 | 0.0775 |
BT-20 | LDN-193189 | 3.33 | uM | LJP5 | 2 | G02 | 72 | hr | 1657 | 2140 | 5505 | 0.3887 | 0.1253 |
BT-20 | LDN-193189 | 3.33 | uM | LJP5 | 3 | G02 | 72 | hr | 1657 | 2337 | 5505 | 0.4245 | 0.1765 |
BT-20 | Linifanib | 3.33 | uM | LJP6 | 1 | J08 | 72 | hr | 1657 | 5400 | 5505 | 0.9808 | 0.9725 |
BT-20 | Linifanib | 3.33 | uM | LJP6 | 2 | J08 | 72 | hr | 1657 | 5455 | 5505 | 0.9908 | 0.9868 |
BT-20 | Linifanib | 3.33 | uM | LJP6 | 3 | J08 | 72 | hr | 1657 | 5774 | 5505 | 1.0487 | 1.0697 |
BT-20 | Linsitinib | 3.33 | uM | LJP5 | 1 | O20 | 72 | hr | 1657 | 4433 | 5505 | 0.8052 | 0.7212 |
BT-20 | Linsitinib | 3.33 | uM | LJP5 | 2 | O20 | 72 | hr | 1657 | 5041 | 5505 | 0.9156 | 0.8792 |
BT-20 | Linsitinib | 3.33 | uM | LJP5 | 3 | O20 | 72 | hr | 1657 | 5029 | 5505 | 0.9134 | 0.8761 |